Détail du document
Identifiant

oai:pubmedcentral.nih.gov:9213...

Sujet
Precision Vaccines Supplement
Auteur
Lofgren, Eric Naumova, Elena N. Gorski, Jack Naumov, Yuri Fefferman, Nina H.
Langue
en
Editeur

Oxford University Press

Catégorie

Oxford University Press Public Health Emergency Collection

Année

2022

Date de référencement

13/01/2023

Mots clés
respiratory theories challenges influenza infections vaccines
Métrique

Résumé

Vaccines against seasonal infections like influenza offer a recurring testbed, encompassing challenges in design, implementation, and uptake to combat a both familiar and ever-shifting threat.

One of the pervading mysteries of influenza epidemiology is what causes the distinctive seasonal outbreak pattern.

Proposed theories each suggesting different paths forwards in being able to tailor precision vaccines and/or deploy them most effectively.

One of the greatest challenges in contrasting and supporting these theories is, of course, that there is no means by which to actually test them.

In this communication we revisit theories and explore how the ongoing COVID-19 pandemic might provide a unique opportunity to better understand the global circulation of respiratory infections.

We discuss how vaccine strategies may be targeted and improved by both isolating drivers and understanding the immunological consequences of seasonality, and how these insights about influenza vaccines may generalize to vaccines for other seasonal respiratory infections.

Lofgren, Eric,Naumova, Elena N.,Gorski, Jack,Naumov, Yuri,Fefferman, Nina H., 2022, How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges, Oxford University Press

Partager

Source

Articles recommandés par ES/IODE IA

Use of ileostomy versus colostomy as a bridge to surgery in left-sided obstructive colon cancer: retrospective cohort study
deviating 0 versus surgery bridge colon study left-sided obstructive stoma colostomy cancer cent